The contribution of related donors to the globally rising number of allogeneic haematopoietic
stem cell transplantations (HSCT) remains increasingly important, particularly because of …

Literature discussing endemic and regionally limited infections in recipients of
haematopoietic stem-cell transplantation (HSCT) outside western Europe and North …

To enhance protective cytomegalovirus (CMV)‐specific T cells in immunosuppressed
recipients of an allogeneic hematopoietic cell transplant (HCT), we evaluated post‐HCT …

In the current post-pandemic era, recipients of an allogeneic hematopoietic stem cell
transplant (HCT) deserve special attention. In these vulnerable patients, vaccine …

Measles is a worldwide viral disease that can cause fatal complications in
immunocompromised hosts such as hematopoietic cell transplant (HCT) recipients. The live …

Patients with haematological malignancies often exhibit reduced antibody responses to
severe acute respiratory syndrome‐related coronavirus vaccines, especially those who have …

Background Hematopoietic cell transplantation (HCT) recipients have reduced antibody
titers to tetanus, diphtheria, and pertussis. Tdap is approved for revaccinating adult HCT …

Collecting umbilical cord stem cells is widely practiced due to its numerous benefits. Over
the past decade, umbilical cord stem cells (UCSCs) have shown effectiveness in treating …

Seasonal community respiratory viral (CRV) infections cause significant morbidity and
mortality in hematopoietic cell transplant (HCT) recipients. This chapter focuses on the …

Enfeksiyöz hastalıklar ve bu hastalıklara bağlı gelişen komplikasyonlar immün yetmezliği
olan hastalarda önemli bir mortalite ve morbidite nedenidir. Bu nedenle aşılar; bulaşıcı …